Organization
SYNARC
3 abstracts
Abstract
A NOVEL SERUM ELISA FOR II COLLAGEN HELICAL DOMAIN DEGRADATION (S-HELIX-II) TO ASSESS CARTILAGE DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITISOrg: Molecular Markers, SYNARC, SYNARC-INSERM U 664,
Abstract
A NEW SERUM BIOCHEMICAL MARKER SPECIFIC OF OXIDATIVE-INDUCED SYNOVIAL TISSUE METABOLISM IN ARTHRITIS: NITROSYLATED N-TELOPEPTIDE OF TYPE III COLLAGEN (IIINYS)Org: Molecular Markers, SYNARC, Lyon cedex 03, France, Clinical Cell biology,
Abstract
ABATACEPT SUSTAINS INHIBITION OF RADIOGRAPHIC PROGRESSION OVER 2 YEARS IN RHEUMATOID ARTHRITIS (RA) PATIENTS WITH AN INADEQUATE RESPONSE TO METHOTREXATE (MTX): RESULTS FROM THE LONG-TERM EXTENSION (LTE) OF THE AIM TRIALOrg: SYNARC, Global Biometric Sciences, Bristol-Myers Squibb, Princeton, United States, Bristol-Myers Squibb, Albany Medical College,